Recent research suggests that GLP-1 drugs, often used for weight loss, may also have the potential to fight cancer. But how can an injectable weight-loss drug contribute to cancer treatment? The answer lies in their ability to activate AMPK, the master regulator of metabolism, by reducing hunger. One of AMPK’s lesser-known benefits is its role as a tumor suppressor.

While GLP-1 drugs offer this advantage, Metabolic Engineering® may provide a more comprehensive approach to preventing the growth of transformed cells. By utilizing a variety of dietary pathways to activate AMPK, Metabolic Engineering delivers sustained benefits beyond what injections alone can achieve.

Explore the science behind these findings and discover why addressing metabolism is key to fighting chronic diseases.